The Landscape of GLP-1 Prescriptions in Germany: A Comprehensive GuideThe pharmaceutical landscape in Germany has gone through a substantial shift over the last two years, driven mostly by the global surge in demand for GLP-1 (Glucagon-like peptide-1) receptor agonists. Initially developed to treat Type 2 diabetes, these medications have gained
